|
FY2025
12 months to Aug 31, 2025
|
FY2024
12 months to Aug 31, 2024
|
FY2023
12 months to Aug 31, 2023
|
FY2022
12 months to Aug 31, 2022
|
FY2021
12 months to Aug 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Operating expenses | |||||
| Selling, general and administrative | |||||
| Research and development | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other income (expense) | |||||
| Interest income | |||||
| Impairment of fixed assets | |||||
| Total other income (expense) | |||||
| Net loss from continuing operations | |||||
| Net loss from discontinued operations | |||||
| Deemed dividend attributable to warrant modification | |||||
| Net loss attributable to common stockholders | |||||
| Other comprehensive income | |||||
| Foreign currency translation gain | |||||
| Comprehensive loss | |||||
| Loss per Share from continuing operations basic | |||||
| Loss per Share from continuing operations diluted | |||||
| Loss per Share from discontinued operations basic | |||||
| Loss per Share from discontinued operations diluted | |||||
| Loss per Share basic | |||||
| Loss per Share diluted | |||||
| Weighted average number of common shares outstanding - basic | |||||
| Weighted average number of common shares outstanding - diluted | |||||
Loading...